Hospital
Fletcher Hospital INC.
Fletcher Hospital INC. was paid $12.01M by Medicaid between Jan 2018 and Dec 2024, across 137 billing codes. Its largest line is 99284, emergency room visit (serious) — 26% of everything it billed.
33Billing provider infoFLETCHER HOSPITAL INC.
HENDERSONVILLE, NC 28792
HENDERSONVILLE, NC 28792
33aNPI1427075027assigned 07/17/2006
33bProvider typeRural Acute Care Hospital
28Total paid$12.01M
24GClaims296,649
24DCodes billed137
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 38,017 | $1.18M | |
| 2019 | 40,978 | $1.26M | |
| 2020 | 25,402 | $617K | |
| 2021 | 46,482 | $1.46M | |
| 2022 | 52,913 | $2.04M | |
| 2023 | 44,656 | $2.50M | |
| 2024incomplete | 48,201 | $2.96M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 26% | 13,855 | 12,530 | $3.12M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 22% | 16,936 | 15,608 | $2.65M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 4,247 | 3,696 | $1.41M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 9.3% | 48,289 | 38,673 | $1.12M |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 4.0% | 3,793 | 3,291 | $485K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.9% | 431 | 377 | $471K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.1% | 6,742 | 6,073 | $375K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.4% | 3,261 | 2,706 | $285K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.0% | 5,978 | 5,134 | $245K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.3% | 3,299 | 2,934 | $153K |
| 99199 | Unlisted special service, procedure or report | 1.2% | 47,632 | 46,531 | $142K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.2% | 20,693 | 17,733 | $142K |
125 more codes
| 80053 | Comprehensive metabolic panel | 1.0% | 16,375 | $121K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 9,445 | $118K |
| 87428 | <1% | 1,402 | $110K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 2,740 | $95K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 563 | $93K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,118 | $90K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 5,907 | $68K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 796 | $63K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 918 | $54K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 687 | $44K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,433 | $37K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,025 | $34K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,074 | $33K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,585 | $32K |
| 81001 | <1% | 9,481 | $29K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 305 | $29K |
| 92587 | <1% | 1,062 | $26K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 68 | $23K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 2,026 | $20K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,672 | $18K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 176 | $16K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 157 | $15K |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,453 | $15K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 533 | $14K |
| 84703 | <1% | 1,387 | $13K | |
| 90837 | Psychotherapy session, about an hour | <1% | 401 | $13K |
| 81003 | <1% | 5,157 | $13K | |
| 83690 | <1% | 1,889 | $13K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 399 | $12K |
| 96127 | <1% | 625 | $12K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,297 | $11K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 16 | $10K |
| 92557 | <1% | 410 | $9K | |
| 99493 | <1% | 151 | $8K | |
| 81002 | <1% | 1,904 | $6K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 158 | $6K |
| 84484 | <1% | 772 | $6K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 185 | $5K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 805 | $5K |
| 87070 | <1% | 452 | $5K | |
| 87806 | <1% | 182 | $5K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,105 | $5K |
| 81025 | <1% | 579 | $4K | |
| 86592 | <1% | 833 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 161 | $4K |
| 92552 | <1% | 183 | $4K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,235 | $3K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 39 | $3K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 40 | $3K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 174 | $2K |
| 86850 | <1% | 179 | $2K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 16 | $2K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 339 | $2K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 25 | $2K |
| 96367 | <1% | 92 | $2K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 36 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 49 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 49 | $2K |
| 76830 | Ultrasound, transvaginal | <1% | 50 | $2K |
| 80061 | Lipid panel | <1% | 131 | $1K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 13 | $1K |
| 87807 | <1% | 95 | $1K | |
| 97597 | <1% | 42 | $1K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 26 | $977.63 |
| 0011A | <1% | 20 | $960.00 | |
| 0012A | <1% | 17 | $960.00 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 29 | $950.97 |
| 84112 | <1% | 13 | $918.13 | |
| 90686 | <1% | 2,701 | $906.78 | |
| 85027 | <1% | 101 | $848.36 | |
| 87081 | <1% | 76 | $741.65 | |
| 0031A | <1% | 21 | $678.73 | |
| 86901 | <1% | 177 | $664.68 | |
| 92567 | <1% | 109 | $634.87 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 97 | $617.26 |
| 86900 | <1% | 180 | $579.77 | |
| 92570 | <1% | 68 | $575.20 | |
| 99494 | <1% | 13 | $556.67 | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 12 | $498.75 |
| 80076 | <1% | 72 | $472.75 | |
| 90474 | <1% | 63 | $467.28 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 93 | $454.91 |
| 92551 | <1% | 178 | $436.17 | |
| 94760 | <1% | 418 | $432.60 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 797 | $417.90 |
| 59025 | Fetal non-stress test | <1% | 15 | $399.92 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 165 | $309.92 |
| 82950 | <1% | 52 | $301.92 | |
| J3490 | Unclassified drugs | <1% | 92 | $297.04 |
| 82150 | <1% | 49 | $274.72 | |
| D1206 | Topical application of fluoride varnish | <1% | 17 | $265.89 |
| 82565 | <1% | 59 | $249.67 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 42 | $197.81 |
| J2704 | Injection, propofol, 10 mg | <1% | 16 | $176.51 |
| 99173 | <1% | 158 | $167.99 | |
| 82947 | <1% | 111 | $156.48 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 13 | $154.10 |
| 86140 | <1% | 26 | $153.75 | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 64 | $151.98 |
| 85652 | <1% | 27 | $83.49 | |
| 90670 | <1% | 1,758 | $76.16 | |
| 90681 | <1% | 43 | $73.53 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 16 | $65.50 |
| 90688 | <1% | 100 | $44.00 | |
| 90734 | <1% | 16 | $42.77 | |
| 90647 | <1% | 405 | $37.04 | |
| 90744 | <1% | 12 | $26.73 | |
| 90648 | <1% | 97 | $22.92 | |
| 90656 | <1% | 124 | $18.75 | |
| 85018 | <1% | 16 | $5.90 | |
| 90633 | <1% | 41 | $5.35 | |
| 90723 | 0% | 575 | $0.00 | |
| 1036F | 0% | 1,494 | $0.00 | |
| 3008F | 0% | 3,337 | $0.00 | |
| 3074F | 0% | 1,788 | $0.00 | |
| 90698 | 0% | 70 | $0.00 | |
| 90716 | 0% | 51 | $0.00 | |
| 90677 | 0% | 40 | $0.00 | |
| 90680 | 0% | 12 | $0.00 | |
| 90685 | 0% | 145 | $0.00 | |
| 1159F | 0% | 3,737 | $0.00 | |
| 1160F | 0% | 3,941 | $0.00 | |
| 3078F | 0% | 1,737 | $0.00 | |
| 90707 | 0% | 66 | $0.00 | |
| 90700 | 0% | 29 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBURROUGHS, STEVEN (CFO)
| Provider | Location | Paid |
|---|---|---|
| Genesiscare USA of North Carolina, PA | Asheville, NC | $111K |
| Genesiscare USA of North Carolina, PA | Asheville, NC | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.